Graft-vs-Host Disease | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

124,938 results for “Graft-vs-Host Disease”

Trials

View all 100536 →

Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)

19 participants · First posted Sep 12, 2013

Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease

20 participants · First posted Jul 8, 2015

Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease

50 participants · First posted Jul 31, 2015

Drugs

View all 1595 →

Graft vs. Host Disease(Aegle)

Graft-versus-host disease therapeutics (Mallinckrodt)

Graft-versus-host disease therapy(Applied StemCell, Inc.)

Organizations

View all 185 →

Vascular Graft Solutions Ltd.

Israel

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

News

View all 22622 →

FDA Approves Axatilamab for Chronic Graft-versus-Host Disease After Breakthrough Discovery

NCCN Guidelines Update: Evolving Treatment Landscape for Graft-vs-Host Disease Management

European Regulators Reject Sanofi's Rezurock for Chronic Graft-vs-Host Disease Treatment

Page 1 of 12494